Cilacar 20mg (Cilnidipine)

What is Cilacar 20mg (Cilnidipine)

Cilacar 20mg contains the active ingredient cilnidipine, a dual‑acting calcium‑channel blocker that relaxes vascular smooth muscle and reduces peripheral resistance. It is classified under the therapeutic class of antihypertensives and is used primarily to manage essential hypertension in adult patients.

Uses and Benefits

The primary use of Cilacar 20mg is to lower elevated blood pressure, thereby reducing the risk of cardiovascular events such as stroke, myocardial infarction, and renal impairment. Clinical studies have demonstrated that regular use of cilnidipine can achieve a mean systolic reduction of 10–15 mm Hg when administered as monotherapy or in combination with other antihypertensive agents. Additional benefits include:

• Improved tolerability compared with first‑generation dihydropyridines, with a lower incidence of peripheral edema.
• Once‑daily dosing that supports medication adherence.
• Suitable for patients with concomitant metabolic risk factors.

Long‑term treatment with Cilacar 20mg not only lowers numeric blood‑pressure values but also contributes to regression of left‑ventricular hypertrophy, improves endothelial function, and reduces albuminuria in patients with diabetic nephropathy. These organ‑protective effects are supported by data from large‑scale hypertension trials that demonstrated a 20 % relative reduction in major cardiovascular events when patients achieved target blood‑pressure goals with agents such as cilnidipine.

How It Works

Cilnidipine blocks L‑type voltage‑gated calcium channels in vascular smooth muscle cells, leading to inhibition of calcium influx and subsequent relaxation of arterial walls. This vasodilatory effect reduces systemic vascular resistance without significant reflex tachycardia, distinguishing it from some other calcium‑channel blockers. The drug’s dual antagonism at both the dihydropyridine and phenethylamine sites enhances its hemodynamic profile, allowing for effective blood‑pressure reduction at a lower dose.

Pharmacokinetically, cilnidipine is rapidly absorbed after oral administration, reaching peak plasma concentrations within one to two hours. It undergoes extensive hepatic metabolism via the CYP3A4 enzyme pathway, producing inactive metabolites that are eliminated primarily in the feces. The terminal half‑life is approximately 10–12 hours, allowing for once‑daily dosing. Because metabolism depends on CYP3A4, co‑administration with strong CYP3A4 inhibitors (e.g., ketoconazole, clarithromycin) can increase plasma levels and should be avoided or dose‑reduced.

For a deeper scientific overview, you can reference peer‑reviewed research on PubMed or consult the Wikipedia entry on cilnidipine.

Dosage Guidelines

Typical adult dosing for Cilacar 20mg is one tablet taken orally once daily, preferably at the same time each day. The dosage may be adjusted based on individual patient response and comorbidities:

• Initial therapy: 20 mg once daily.
• If additional blood‑pressure reduction is required, a healthcare provider may consider dose escalation to 40 mg once daily, keeping within the maximum recommended daily dose of 80 mg.
• Patients with hepatic impairment should start at a reduced dose of 10 mg daily, if available, and be monitored closely.

In the event of an missed dose, patients should take the tablet as soon as they remember, provided that at least 12 hours have not elapsed since the scheduled dose. If less than 12 hours remain until the next scheduled dose, the missed dose should be skipped and the regular dosing schedule resumed. Double dosing to compensate for a missed tablet is not recommended, as it may increase the risk of adverse effects.

Side Effects

Like all medications, Cilacar 20mg can cause adverse effects. Most side effects are mild and transient, but patients should be aware of the following:

• Headache
• Dizziness or light‑headedness, especially after the first few doses
• Flushing
• Fatigue
• Swelling of the ankles or feet (edema)
• Rare but serious reactions may include rapid heartbeat, severe allergic skin rash, or signs of liver dysfunction such as yellowing of the skin or eyes.
• Rare but clinically significant adverse events include angioedema, severe bradycardia, and hepatic enzyme elevations. Patients should be instructed to seek immediate medical attention if they experience swelling of the face, lips, or throat, or if they notice an unusually slow heart rate.

If any of these symptoms persist or worsen, patients should contact their healthcare provider promptly. For comprehensive safety information, refer to the FDA prescribing information.

Warnings and Precautions

Before initiating therapy with Cilacar 20mg, consider the following precautions:

• Allergy History: Do not use if you are allergic to cilnidipine or any of the inactive ingredients.
• Pregnancy and Breastfeeding: Cilacar is classified as Category C; use only if the potential benefit justifies the potential risk. Discuss with a physician.
• Drug Interactions: Cilacar may interact with other antihypertensive agents, certain antidepressants, and inhibitors of CYP3A4. Provide a complete medication list to your healthcare provider.
• Renal or Hepatic Impairment: Adjust dosage cautiously in patients with severe renal or hepatic disease.
• Surgery: Inform your surgeon or anesthesiologist of current medication, as Cilacar can affect blood pressure control during postoperative recovery.
• Concurrent Use: Patients should be cautioned against the concurrent use of other calcium‑channel blockers or potent vasodilators without medical supervision, as this may lead to excessive hypotension. Additionally, caution is advised when prescribing Cilacar alongside lithium or certain anti‑arrhythmic agents, which may alter electrolyte balance and cardiac conduction.

For detailed guidance, consult the MedlinePlus hypertension page or speak with a qualified pharmacist.

Frequently Asked Questions

1. Can Cilacar 20mg be taken with food? Yes, cilnidipine has high bioavailability and can be taken with or without meals. However, taking it at the same time each day helps maintain consistent blood levels.
2. How long does it take to see a reduction in blood pressure? Most patients experience a measurable drop in systolic and diastolic pressure within 2–4 weeks of regular use, though individual response may vary.
3. Is Cilacar safe for elderly patients? Clinical studies have shown that elderly patients can use Cilacar safely, but dose adjustments and close monitoring are recommended due to potential decreased renal function.
4. Can I drink alcohol while on Cilacar? Moderate alcohol consumption is generally permissible, but excessive intake may exacerbate dizziness or low blood pressure. Discuss with your physician.
5. What should I do if I miss a dose? Take the missed tablet as soon as you remember, unless it is near the time for the next dose. In that case, skip the missed dose and resume your regular schedule; do not double up.

For additional information about hypertension management, visit the National Institutes of Health (NIH) hypertension resources.

Patients are encouraged to adopt complementary lifestyle modifications such as a low‑sodium diet, regular physical activity, weight management, and limiting alcohol intake to enhance the effectiveness of Cilacar 20mg and promote overall cardiovascular health.

Related Products

• Cilnidipine 5 mg (Generic)
• Nicardia XL 30 Mg (Nifedipine)
• Cilacar (Cilnidipine)
• Cilacar 5 mg (Cilnidipine)
• Cilacar 10mg (Cilnidipine)
• Cilacar T (Cilnidipine/Telmisartan)
• Arkamin 100 (Clonidine)
• Abel 40 mg (Azilsartan Medoxomil)
• Metrogyl Gel (Metronidazole)
• Metrogyl Tablet (Metronidazole)
• Metrogyl 200mg (Metronidazole)
• Metrogyl 400mg (Metronidazole)